Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 866

Similar articles for PubMed (Select 17883521)

1.
2.

Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.

Chen LC, Ashcroft DM.

Headache. 2008 Feb;48(2):236-47. doi: 10.1111/j.1526-4610.2007.01007.x. Epub 2007 Dec 27.

PMID:
18179569
4.

Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).

Mathew NT, Finlayson G, Smith TR, Cady RK, Adelman J, Mao L, Wright P, Greenberg SJ; AEGIS Investigator Study Group.

Headache. 2007 Feb;47(2):189-98.

PMID:
17300358
5.

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.

Ferrari MD, Goadsby PJ, Roon KI, Lipton RB.

Cephalalgia. 2002 Oct;22(8):633-58. Erratum in: Cephalalgia. 2003 Feb;23(1):71..

PMID:
12383060
6.

Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials.

Ashcroft DM, Millson D.

Pharmacoepidemiol Drug Saf. 2004 Feb;13(2):73-82.

PMID:
14998068
7.
8.

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.

Ferrari MD, Roon KI, Lipton RB, Goadsby PJ.

Lancet. 2001 Nov 17;358(9294):1668-75.

PMID:
11728541
9.

Spotlight on almotriptan in migraine.

Keam SJ, Goa KL, Figgitt DP.

CNS Drugs. 2002;16(7):501-7. Review.

PMID:
12056924
10.

Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability.

Pascual J, Mateos V, Roig C, Sanchez-Del-Rio M, Jiménez D.

Headache. 2007 Sep;47(8):1152-68. Review.

PMID:
17883520
11.
12.

Almotriptan improves response rates when treatment is within 1 hour of migraine onset.

Dowson AJ, Massiou H, Lainez JM, Cabarrocas X.

Headache. 2004 Apr;44(4):318-22.

PMID:
15109355
13.

Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.

Diener HC, Gendolla A, Gebert I, Beneke M.

Headache. 2005 Jul-Aug;45(7):874-82.

PMID:
15985104
14.

Almotriptan: a review of its use in migraine.

Keam SJ, Goa KL, Figgitt DP.

Drugs. 2002;62(2):387-414. Review.

PMID:
11817980
15.

A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine.

Mathew NT; Oral Almotriptan Study Group.

Headache. 2002 Jan;42(1):32-40.

PMID:
12005273
19.
20.

Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.

Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D.

Headache. 2009 Jul;49(7):971-82. doi: 10.1111/j.1526-4610.2009.01458.x. Epub 2009 May 27.

PMID:
19486178
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk